Kalcijum karbasalat
(Preusmjereno sa stranice VYMUGTALCSPLDM-UHFFFAOYSA-L)
| |
| Kombinacija | |
|---|---|
| Kalcijum acetilsalicilat | NSAID, inhibitor agregacije trombocita |
| Ureja | |
| Klinički podaci | |
| AHFS/Drugs.com | Internacionalno ime leka |
| Identifikatori | |
| CAS broj | 5749-67-7 |
| ATC kod | B01AC08 |
| PubChem[1][2] | 21975 |
| ChemSpider[3] | 20651 |
| UNII | N667F17JP1 
|
| Farmakoinformacioni podaci | |
| Trudnoća | ? |
| Pravni status | |
| Način primene | Oralno |
Kalcijum karbasalat je inhibitor agregacije trombocita. On je smeđa kalcijum acetilsalicilata (kalicijumove soli aspirina) i ureje.[4][5]
Reference[uredi | uredi kod]
- ↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.
- ↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
- ↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846.
- ↑ LeJeunne C, Gómez JP, Pradalier A, Titus i Albareda F, Joffroy A, Liaño H, Henry P, Lainez JM, Geraud G (1999). „Comparative Efficacy and Safety of Calcium Carbasalate plus Metoclopramide versus Ergotamine Tartrate plus Caffeine in the Treatment of Acute Migraine Attacks”. European Neurology 41 (1): 37–43. DOI:10.1159/000007996.
- ↑ „http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowAbstractBuch&ArtikelNr=7996&ProduktNr=224966”.
